{"nct_id":"NCT06319456","title":"A Global Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.","status":"RECRUITING","status_verified_date":"2024-05","start_date":"2024-04-07","start_date_type":"ACTUAL","primary_completion_date":"2027-08","primary_completion_date_type":"ESTIMATED","completion_date":"2028-08","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AAPG"]}